SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
布谷
Lv1
1
50 积分
2021-11-21 加入
最近求助
最近应助
互助留言
The Comparison of Kte-X19 to Current Standards of Care: A Pre-Specified Synthetic Control Study Utilizing Individual Patient Level Data from Historic Clinical Trials (SCHOLAR-3)
7小时前
求助中
Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia
6天前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
8天前
已完结
Approval of brexucabtagene autoleucel for adults with relapsed and refractory acute lymphocytic leukemia
11天前
已完结
End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL)
12天前
已关闭
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
12天前
已完结
Progress in the Treatment of Malignant Ascites
25天前
已完结
Identification of three different phenotypes in anti‐MDA5 antibody‐positive dermatomyositis patients: implications for rapidly progressive interstitial lung disease prediction
1年前
已完结
A computed tomography radiomics-based prediction model on interstitial lung disease in anti-MDA5 positive dermatomyositis
2年前
已关闭
没有进行任何应助
感谢
6天前
速度真快,帮大忙了
8天前
感谢
11天前
速度真快,感谢
25天前
非常感谢,速度真快,帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论